Geoffrey Neil Hamilton-Fairley
Director/Board Member chez Oncimmune Ltd.
Profil
Geoffrey Neil Hamilton-Fairley is currently the Non-Executive Vice Chairman at Oncimmune Ltd.
He is also a Non-Executive Director at Roslin Cell Therapies Ltd.
and an Operating Partner at GHO Capital Partners LLP.
Previously, he served as the Chief Executive Officer at Premium TV Ltd.
and as the Vice Chairman at Oncimmune Holdings Plc from 2018 to 2020.
He also worked as a Director at Abingdon Management Co. Ltd.
Postes actifs de Geoffrey Neil Hamilton-Fairley
Sociétés | Poste | Début |
---|---|---|
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | 01/01/2005 |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/01/2020 |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022. | Director/Board Member | - |
Anciens postes connus de Geoffrey Neil Hamilton-Fairley
Sociétés | Poste | Fin |
---|---|---|
ONCIMMUNE HOLDINGS PLC | Chairman | 30/06/2020 |
Premium TV Ltd.
Premium TV Ltd. Miscellaneous Commercial ServicesCommercial Services Premium TV Ltd. acquires, promotes, develops media, sporting rights and interests. It broadcasts different sports and events through its channels. The company is located in London, UK. | Chief Executive Officer | - |
Abingdon Management Co. Ltd.
Abingdon Management Co. Ltd. Real Estate DevelopmentFinance Abingdon Management Co. Ltd. provides real estate services. | Director/Board Member | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ONCIMMUNE HOLDINGS PLC | Health Technology |
Entreprise privées | 5 |
---|---|
Premium TV Ltd.
Premium TV Ltd. Miscellaneous Commercial ServicesCommercial Services Premium TV Ltd. acquires, promotes, develops media, sporting rights and interests. It broadcasts different sports and events through its channels. The company is located in London, UK. | Commercial Services |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Abingdon Management Co. Ltd.
Abingdon Management Co. Ltd. Real Estate DevelopmentFinance Abingdon Management Co. Ltd. provides real estate services. | Finance |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022. | Health Technology |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Finance |